Physician

Devang A. Gandhi, M.D.

According to 2025 Medicare claims, Devang Gandhi, M.D. (NPI: 1225038755) practices nuclear medicine in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is BARNABAS HEALTH MEDICAL GROUP PC (NPI: 1841557246; TIN: 454832340) and primary practice location at 07052-2750. Gandhi is affiliated with the Optimus Healthcare Partners, LLC (ACO ID: A1059), RWJBH Accountable Care, LLC (ACO ID: A1247), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Gandhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,346 traditional Medicare patients, billed 4,981 HCPCS/CPT codes, and received $220,350 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,227 prescription claims across 487 beneficiaries totaling $392,972 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 66 records totaling $962. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $328,789 to $392,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,316	4,099	$228,986
2016	1,545	4,823	$265,508
2017	1,587	4,858	$293,525
2018	1,978	5,386	$261,813
2019	1,871	4,692	$215,368
2020	1,785	4,011	$189,365
2021	1,664	3,880	$222,656
2022	2,004	4,606	$251,860
2023	2,199	4,614	$215,693
2024	2,346	4,981	$220,350

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	348	2,812	$328,789
2016	385	3,162	$278,739
2017	423	2,700	$264,788
2018	383	1,818	$208,019
2019	366	1,724	$243,529
2020	361	1,827	$333,852
2021	360	1,792	$361,897
2022	419	2,038	$394,264
2023	470	2,104	$407,842
2024	487	2,227	$392,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	603	1,166	$100
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	501	509	$54
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	122	122	$16
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	649	1,114	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,087	1,368	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	113	7,801	$148,105
Repatha Sureclick	Evolocumab	38	2,036	$38,462
Entresto	Sacubitril/Valsartan	19	1,410	$31,690
Xarelto	Rivaroxaban	14	1,140	$20,591
Carvedilol Er	Carvedilol Phosphate	12	1,080	$6,847

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$962	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Devang A. Gandhi, M.D.?

Tedicare shows public-source Medicare data for Devang A. Gandhi, M.D. (NPI 1225038755), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Devang A. Gandhi, M.D. have ACO affiliation data?

Devang A. Gandhi, M.D. is shown with ACO affiliation data for Optimus Healthcare Partners, LLC (MSSP, ACO ID A1059), RWJBH Accountable Care, LLC (MSSP, ACO ID A1247), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Devang A. Gandhi, M.D.?

Devang A. Gandhi, M.D. is linked to BARNABAS HEALTH MEDICAL GROUP PC (billing NPI 1841557246) in the available physician profile data.

Does Devang A. Gandhi, M.D. have Open Payments data?

Devang A. Gandhi, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.